HLHelena Santos de Moura Lima

Helena Santos de Moura Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Helena Santos de Moura Lima has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A challenging case of Down syndrome regression disorder

    by Letícia Klabinske Marques Monteiro, Aimê de Paula Santos, Helena Santos de Moura Lima, Rejane de Souza Macedo Campos, Jesus Manoel Bernardez Gandara, Luziany Carvalho Araújo, Breno José Alencar Pires Barbosa

    Down syndrome regression disorder (DSRD) is a rare cause of neuropsychiatric regression observed in previously-healthy individuals with Down syndrome (DS). There have been reports of brain iron accumulation in the basal ganglia of patients with DS and DSRD, although the underlying etiology remains unclear. The current study aims to report, through detailed neuroimaging, laboratory tests, and clinical data findings, the case of a patient with DS who experienced a significant loss of abilities, accompanied by neuroimaging findings indicative of abnormal brain iron accumulation. While an extensive investigation with blood, cerebrospinal fluid (CSF), and genetic markers was unremarkable, magnetic resonance imaging (MRI) scans revealed abnormal iron deposition and calcifications in the globus pallidus. The abnormal iron accumulation in the basal ganglia of patients with DSRD could be a potential neuroimaging marker for this condition.

    • 12 May 2026
      • Vol. 84  (8) , 1-5
    Open Access

    A challenging case of Down syndrome regression disorder.

    by Letícia Klabinske Marques Monteiro, Aimê de Paula Santos, Helena Santos de Moura Lima, Rejane de Souza Macedo Campos, Jesus Manoel Bernardez Gandara, Luziany Carvalho Araújo, Breno José Alencar Pires Barbosa

    Down syndrome regression disorder (DSRD) is a rare cause of neuropsychiatric regression observed in previously-healthy individuals with Down syndrome (DS). There have been reports of brain iron accumulation in the basal ganglia of patients with DS and DSRD, although the underlying etiology remains unclear. The current study aims to report, through detailed neuroimaging, laboratory tests, and clinical data findings, the case of a patient with DS who experienced a significant loss of abilities, accompanied by neuroimaging findings indicative of abnormal brain iron accumulation. While an extensive investigation with blood, cerebrospinal fluid (CSF), and genetic markers was unremarkable, magnetic resonance imaging (MRI) scans revealed abnormal iron deposition and calcifications in the globus pallidus. The abnormal iron accumulation in the basal ganglia of patients with DSRD could be a potential neuroimaging marker for this condition.

  • Open Access

    Use of artificial intelligence in predicting cognitive decline and dementia: a systematic review

    by Breno José Alencar Pires Barbosa, Tatiana Caldas Neves da Silva, Maria Eduarda Souza Belmino Lins, Giovana Oliveira Fernandes Pinto, Laís Maria de Luna, Caylane Mayssa de Lima Simões, Helena Santos de Moura Lima, Joana D’aRc Oliveira de Mendonça, Ana Paula Silva de Oliveira

    The use of Artificial Intelligence (AI) and Machine Learning (ML) has been applied in several studies to detect the conversion from mild cognitive impairment (MCI) to dementia. This study aims to identify challenges and effective methods for applying AI in predicting cognitive decline and dementia. A literature review was conducted by searching the PubMed database between May and July 2024, using predefined eligibility criteria. The analysis included 17 studies involving 12,183 participants (aged 50 to 85 years). The review included 17 articles published between 2015 and 2023, predominantly observational studies. The AI tools applied encompassed demographic and lifestyle data, imaging exams, cognitive tests, biomarkers, and physiological data. MCI was the most prevalent diagnosis among the studies, with a particular focus on the amnestic subtype. Nine studies investigated the conversion from MCI to some form of dementia; four analyzed the prediction of beta-amyloid positivity; three employed ML for diagnostic support in distinguishing controls from patients with different types of dementia; and one assessed the cognitive risk in an elderly population. Among the best-performing approaches identified, multimodal data strategies — especially those involving MRI imaging and sociodemographic information — stood out. Applications involving multimodal datasets, particularly those including MRI exams, improve the overall performance of ML models and are considered among the most effective approaches. Future research should focus on the diagnosis and prediction of less-studied dementias, such as frontotemporal dementia, through the use of AI. The integration of multimodal data, including demographic information, imaging exams, cognitive assessments, and biomarkers, should be encouraged.